Plasma exchange in neurology patients-experience from single center in Montenegro

被引：0

作者：

Roganovic, Milovan ^{[1
,3
]}

Erakovic, Jevto ^{[1
]}

Radulovic, Ljiljana ^{[1
,2
]}

Perunicic, Slavisa ^{[1
]}

Milikic, Dragica ^{[1
]}

Vujovic, Balsa ^{[1
,2
]}

Idrizovic, Zilha ^{[1
]}

Vujovic, Sandra ^{[1
]}

Debeljevic, Mladen ^{[1
]}

Gluscevic, Sanja ^{[1
]}

机构：

[1] Clin Ctr Montenegro, Clin Neurol, Podgorica, Montenegro

[2] Univ Montenegro, Fac Med, Podgorica, Montenegro

[3] Clin Ctr Montenegro, Clin Neurol, Podgorica 81000, Montenegro

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 01期

关键词：

experience; Guillain-Barre syndrome; multiple sclerosis; myasthenia gravis; plasma exchange; APHERESIS; THERAPY;

D O I：

10.1111/1744-9987.14062

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Plasma exchange (PE) is widely used in many immune-based neurological diseases. Our aim is to analyze characteristics of PE in neurological patients at the Clinical Center of Montenegro.Methods: Our study involved neurological patients treated with PE between January 2020 and April 2022.Results: In total, 246 PEs were performed in 43 patients. We divided patients into 4 groups according to indications. In 8/9 multiple sclerosis (MS) patients a decrease of Expanded Dysability Status Scale at least 0.5 was verified. In 14/20 Guillain Barre syndrome patients reduction of Hughes was observed. Four patients with myasthenia gravis (MG) were treated with PE. The most heterogeneous group (4) consisted of patients in whom the mechanism of disease development is assumed to be immune system dysregulation. Fourteen patients had any adverse event.Conclusion: Our results show that PE is widely used and safe in the treatment of neurological diseases.

引用

页码：125 / 130

页数：6

共 14 条

[1]

ABEL JJ, 1990, TRANSFUS SCI, V11, P166

[2] PLASMAPHERESIS AND IMMUNOSUPPRESSIVE DRUG-THERAPY IN MYASTHENIA-GRAVIS [J].

DAU, PC ;

LINDSTROM, JM ;

CASSEL, CK ;

DENYS, EH ;

SHEV, EE ;

SPITLER, LE .

NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (21) :1134-1140

[3] Safety and tolerability of therapeutic plasma exchange in autoimmune neurological diseases - a retrospective single-centre analysis [J].

Gala-Bladzinska, Agnieszka ;

Mazur, Katarzyna ;

Debiec, Adam ;

Gargasz, Krzysztof ;

Bartosik-Psujek, Halina .

NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (04) :344-349

[4] Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis [J].

Hauser, S. L. ;

Bar-Or, A. ;

Comi, G. ;

Giovannoni, G. ;

Hartung, H. -P. ;

Hemmer, B. ;

Lublin, F. ;

Montalban, X. ;

Rammohan, K. W. ;

Selmaj, K. ;

Traboulsee, A. ;

Wolinsky, J. S. ;

Arnold, D. L. ;

Klingelschmitt, G. ;

Masterman, D. ;

Fontoura, P. ;

Belachew, S. ;

Chin, P. ;

Mairon, N. ;

Garren, H. ;

Kappos, L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (03) :221-234

[5] Adverse events in apheresis: An update of the WAA registry data [J].

Henriksson, M. Mortzell ;

Newman, E. ;

Witt, V. ;

Derfler, K. ;

Leitner, G. ;

Eloot, S. ;

Dhondt, A. ;

Deeren, D. ;

Rock, G. ;

Ptak, J. ;

Blaha, M. ;

Lanska, M. ;

Gasova, Z. ;

Hrdlickova, R. ;

Ramlow, W. ;

Prophet, H. ;

Liumbruno, G. ;

Mori, E. ;

Griskevicius, A. ;

Audzijoniene, J. ;

Vrielink, H. ;

Rombout, S. ;

Aandahl, A. ;

Sikole, A. ;

Tomaz, J. ;

Lalic, K. ;

Mazic, S. ;

Strineholm, V. ;

Brink, B. ;

Berlin, G. ;

Dykes, J. ;

Toss, F. ;

Axelsson, C. G. ;

Stegmayr, B. ;

Nilsson, T. ;

Norda, R. ;

Knutson, F. ;

Ramsauer, B. ;

Wahlstrom, A. .

TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) :2-15

[6] Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products [J].

Howell, C. ;

Douglas, K. ;

Cho, G. ;

El-Ghariani, K. ;

Taylor, P. ;

Potok, D. ;

Rintala, T. ;

Watkins, S. .

TRANSFUSION MEDICINE, 2015, 25 (02) :57-78

[7] The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review [J].

Jacob, Saiju ;

Mazibrada, Gordon ;

Irani, Sarosh R. ;

Jacob, Anu ;

Yudina, Anna .

JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2021, 16 (04) :806-817

[8]

Kusunoki Susumu, 2015, Brain Nerve, V67, P1295, DOI 10.11477/mf.1416200299

[9] Therapeutic plasma exchange in MS refractory relapses: Long-term outcome [J].

Marrodan, M. ;

Crema, S. ;

Rubstein, A. ;

Alessandro, L. ;

Fernandez, J. ;

Correale, J. ;

Ysrraelit, M. C. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55

[10] Plasma exchange in neurological disease [J].

Osman, Chinar ;

Jennings, Rachel ;

El-Ghariani, Khaled ;

Pinto, Ashwin .

PRACTICAL NEUROLOGY, 2020, 20 (02) :92-+

← 1 2 →